4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-049967
EVP, Research & CSO sold 5,560 shares at $42.92 ($238,632)
- EVP, Research & CSO acquired 25,560 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2020-08-25 | Option exercise | +25,560 | $1.53 | $39,107 | 25,560 | D |
| Virgin Herbert EVP, Research & CSO | 2020-08-25 | Sale | −5,560 | $42.92 | $238,632 | 20,000 | D |
| Derivatives | |||||||
| Virgin Herbert EVP, Research & CSO | 2020-08-25 | Option exercise · Stock Option (Right to Buy) | −25,560 | 474,695 | D | ||
| Open-market sales · 5,560 sh · avg $42.92 · $238,632 | |||||||
Loading xslF345X03/doc4.xml…